A personalized iodine delivery rate-based injection protocol in coronary angiography on photon-counting CT - Scorecard - MDSpire

A personalized iodine delivery rate-based injection protocol in coronary angiography on photon-counting CT

  • By

  • Tim Busselot

  • Pierpaolo Giordano

  • Vincent Sneyers

  • Walter Coudyzer

  • Kwinten Torfs

  • Tom Adriaenssens

  • Hilde Bosmans

  • Steven Dymarkowski

  • March 6, 2026

  • 0 min

Share

Clinical Scorecard: An Individualized Protocol for Iodine Injection Rates in Coronary Angiography Utilizing Photon-Counting CT

At a Glance

CategoryDetail
ConditionCoronary artery disease (CAD) assessment via coronary CT angiography (cCTA)
Key MechanismsPersonalized iodine delivery rate (IDR) injection protocols optimized for photon-counting CT (PCCT) to achieve target coronary vessel enhancement
Target PopulationAdult patients referred for clinically indicated cCTA to exclude CAD, excluding those with renal dysfunction (eGFR < 30), ICM hypersensitivity, or pregnancy
Care SettingCardiovascular imaging in hospital radiology departments using PCCT scanners

Key Highlights

  • Photon-counting CT enables spectral imaging with virtual mono-energetic images (VMI) optimizing vessel enhancement and plaque quantification.
  • Personalized iodine delivery rate (IDR) protocols based on body metrics can achieve consistent coronary enhancement (350-500 HU) while minimizing total iodine dose.
  • A biphasic injection protocol with fixed injection times and personalized IDR was validated prospectively, showing feasibility and safety without extravasation events.

Guideline-Based Recommendations

Diagnosis

  • Use PCCT with high-pitch ECG-gated spectral acquisition mode for cCTA to evaluate coronary arteries.
  • Administer sublingual nitroglycerin and beta-blockers if heart rate >70 bpm prior to scanning.

Management

  • Apply a biphasic contrast injection protocol with a personalized iodine delivery rate based on body habitus metrics.
  • Use a fixed injection time (17 seconds) with variable injection rates (3.5 or 5.0 mL/s) and iodine concentration dilution to achieve target coronary enhancement.
  • Follow contrast bolus with a saline chaser at matched injection rate.

Monitoring & Follow-up

  • Monitor coronary enhancement via HU measurements in the ascending aorta to ensure target enhancement of 350-500 HU.
  • Use bolus-tracking with ROI in descending aorta and threshold of 140 HU at 90 kVp to time scan acquisition.

Risks

  • Exclude patients with renal dysfunction (eGFR < 30 mL/min/1.73 m2), known hypersensitivity to iodinated contrast media, and pregnancy.
  • No extravasation events were recorded with the proposed injection protocols.

Patient & Prescribing Data

Adults undergoing cCTA for CAD exclusion with no severe renal impairment or contrast allergy

Personalized IDR-based contrast injection protocols allow tailored iodine dosing to achieve consistent coronary enhancement with minimized iodine load, validated prospectively with fixed injection times and variable injection rates.

Clinical Best Practices

  • Calculate personalized iodine delivery rate using body habitus metrics to optimize contrast volume and injection rate.
  • Use dual-head power injectors with biphasic injection protocols combining iodinated contrast and saline chaser.
  • Perform ECG-gated high-pitch PCCT scans with appropriate premedication (nitroglycerin, beta-blockers) to improve image quality.
  • Employ bolus-tracking techniques to precisely time scan acquisition for optimal vessel enhancement.

References

Original Source(s)

Related Content